EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Serum Albumin-Coated Bone Allograft for Bone Regeneration: A Seven-Year Follow-Up Study of 26 Cases

Kata K Gyulay iD, Péter Karászi, Mátyás Rédei, Petra Sólymos, Károly Schandl, Zsombor Lacza, Dénes B Horváthy iD

International Journal of Molecular Sciences · 25.05.2023 · 24 (11) · 9232

DOI: 10.3390/ijms24119232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2023. Verfasst von Kata K Gyulay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Heart and Vascular Centre, Semmelweis University, 1122 Budapest, Hungary. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament Injuries, Bone Substitutes, Patellar Ligament. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Semmelweis University, OrthoSera GmbH, Saint George University Teaching Hospital of County-Fejér.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have previously reported that serum albumin-coated bone allograft (BoneAlbumin, BA) is an effective bone substitute. It improves bone regeneration at the patellar and tibial donor sites six months after harvesting bone-patellar tendon-bone (BPTB) autografts for primary anterior cruciate ligament reconstruction (ACLR). In the present study, we examined these donor sites seven years after implantation. The study group (N = 10) received BA-enhanced autologous cancellous bone at the tibial and BA alone at the patellar site. The control group (N = 16) received autologous cancellous bone at the tibial and blood clot at the patellar site. We evaluated subcortical density, cortical thickness, and bone defect volume via CT scans. At the patellar site, subcortical density was significantly higher in the BA group at both time points. There was no significant difference in cortical thickness between the two groups at either donor site. The control group’s bone defect significantly improved and reached the BA group’s values at both sites by year seven. Meanwhile, the bone defects in the BA group did not change significantly and were comparable to the six-month measurements. No complications were observed. There are two limitations in this study: The number of patients recruited is small, and the randomization of the patients could have improved the quality of the study as the control group patients were older compared to the study group patients. Our 7-year results seem to demonstrate that BA is a safe and effective bone substitute that supports faster regeneration of donor sites and results in good-quality bone tissue at the time of ACLR with BPTB autografts. However, studies with a larger number of patients are required to definitively confirm the preliminary results of our study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anterior Cruciate Ligament InjuriesBone SubstitutesPatellar LigamentHumansFollow-Up StudiesBone-Patellar Tendon-Bone GraftingSerum AlbuminTransplantation, AutologousAllograftsBone Regeneration

Stichwörter der Autor:innen

BTBBoneAlbuminanterior cruciate ligament replacementbone allograftbone substitutebone–tendon–bone autograftdonor site morbidityradiomorphologyserum albumin

Substanzen

Serum AlbuminBone Substitutes

Autor:innen und Institutionen

  • Department of Interventional Radiology, Heart and Vascular Centre, Semmelweis University, 1122 Budapest, Hungary.
  • Department of Radiology, Medical Imaging Centre, Semmelweis University, 1083 Budapest, Hungary.
  • Department of Sports Surgery, Saint George University Teaching Hospital of County-Fejér, 8000 Székesfehérvár, Hungary.
  • Department of Sports Physiology, University of Physical Education, 1123 Budapest, Hungary.
  • Translational Medicine Institute, Semmelweis University, 1085 Budapest, Hungary.

ORCID-Profile: Kata K Gyulay, Dénes B Horváthy

Förderung

  • Semmelweis University
  • OrthoSera GmbH
  • Saint George University Teaching Hospital of County-Fejér
  • Semmelweis University, Budapest, Hungary
  • Saint George University Teaching Hospital of County-Fejér, Székesfehérvár, Hungary

Zitieren

APA

Gyulay, K. K., Karászi, P., Rédei, M., Sólymos, P., Schandl, K., Lacza, Z., & Horváthy, D. B. (2023). Evaluation of Serum Albumin-Coated Bone Allograft for Bone Regeneration: A Seven-Year Follow-Up Study of 26 Cases. International Journal of Molecular Sciences, 24(11), 9232. https://doi.org/10.3390/ijms24119232

Vancouver

Gyulay KK, Karászi P, Rédei M, Sólymos P, Schandl K, Lacza Z, et al. Evaluation of Serum Albumin-Coated Bone Allograft for Bone Regeneration: A Seven-Year Follow-Up Study of 26 Cases. International Journal of Molecular Sciences. 2023;24(11):9232. doi:10.3390/ijms24119232

BibTeX
@article{Gyulay2023,
  author = {Gyulay, Kata K and Karászi, Péter and Rédei, Mátyás and Sólymos, Petra and Schandl, Károly and Lacza, Zsombor and Horváthy, Dénes B},
  title = {Evaluation of Serum Albumin-Coated Bone Allograft for Bone Regeneration: A Seven-Year Follow-Up Study of 26 Cases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {9232},
  doi = {10.3390/ijms24119232}
}
Kostenlos starten →